The success of NIPRO’s biosimilar product, launched in late 2023, has exceeded expectations and gained significant market ...

Sanofi and Johnson & Johnson’s E. coli vaccine candidate failed to prevent invasive E. coli disease effectively.

Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...

Will significantly enhance service to researchers and institutions across China.

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, is expanding the scope and ...

Innovative approaches to streamlining biologics production with integrated continuous technologies. Continuous manufacturing ...

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to CUSP06, a Cadherin-6 targeting ...

Alcami Corporation, a contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry ...

The evolution of protocol management within eQMS represents another significant advance in clinical trials. Version control ...

The project is set to become the largest GMP temperature-controlled facility fully dedicated to the life sciences sector in ...

Addresses the significant threat of antimicrobial resistance.